The findings, which showed that GSTs enzymes play crucial role in the detoxification of numerous products induced by cancer therapy, prompted us to evaluate the prognostic significance of GSTs deletions in breast carcinoma. The gene discussed is HPGDS; the disease is breast carcinoma.